Shop by goal
Popular compounds
Research resources
Recently viewed
Eloralintide: Metabolic / Fat Loss research guide
In short: Eloralintide (LY3841136), a selective, long-acting amylin receptor agonist engineered for once-weekly subcutaneous obesity research, with AMY1R-preferring pharmacology. It is studied in preclinical (cell and animal) research and is supplied strictly for laboratory use, not for human or clinical use.
Not medical advice. Eloralintide is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.
Eloralintide at a glance
What to know first
Details and limits sit in the sections below. Research use only.
What Eloralintide is
Eloralintide (LY3841136) is a selective, long-acting amylin receptor agonist engineered for once-weekly dosing, with an amylin-pathway appetite mechanism complementary to GLP-1 receptor agonists.
One-paragraph overview from our research datasheet. Still scientific, but faster to read than the full mechanism list below.
Eloralintide (LY3841136), a selective, long-acting amylin receptor agonist engineered for once-weekly subcutaneous obesity research, with AMY1R-preferring pharmacology.
Research contexts
Peer-reviewed papers discuss Eloralintide in specific lab settings. The points below reflect research questions, not health claims.
Research vs. personal use: Literature describes experiments in cells and animals. That is distinct from real-world use. Our products are for laboratory research only.
Typical study contexts
Why Metabolic / Fat Loss research matters
Metabolic peptides are studied for appetite signals, incretin pathways and energy balance. Literature emphasises mechanisms, not lifestyle advice.
Mechanisms (technical review)
Our datasheet lists mechanistic themes from preclinical work. These are research endpoints, not health claims.
Lab handling & preparation
Common Questions People Are Asking
What is eloralintide and how does it work?
Eloralintide (LY3841136) is a selective, long-acting amylin receptor agonist. It engages the amylin satiety pathway — hindbrain and hypothalamic appetite circuits — to reduce caloric intake, and in vitro it preferentially activates the human AMY1R receptor over the calcitonin receptor and AMY3R subtype. A lipid side chain at Lys26 (two γ-glutamate residues plus a C20 fatty diacid) binds serum albumin to extend its duration of action for once-weekly research dosing.
How is eloralintide different from cagrilintide?
Both are long-acting amylin analogues, but cagrilintide is a non-selective agonist across the amylin receptor family and the calcitonin receptor, whereas eloralintide is reported to be selective — preferentially activating the AMY1R amylin receptor. That selectivity is the main design difference between the two research peptides.
How is eloralintide different from a GLP-1 agonist?
GLP-1 agonists such as semaglutide activate the GLP-1 (incretin) receptor. Eloralintide activates the amylin receptor pathway. The two systems are distinct satiety circuits, which is why eloralintide has been studied both on its own and as a complement to incretin therapy.
What does the research on eloralintide actually show?
Published Phase 1 proof-of-concept research reported that once-weekly eloralintide was well tolerated with minimal gastrointestinal adverse events, and a subsequently reported Phase 2 obesity programme described clinically meaningful body-weight reduction with favourable tolerability. These are descriptive research findings for an investigational compound, not outcomes promised for any use of this research-grade material.
Is eloralintide approved or legal?
Eloralintide is an investigational compound (LY3841136) and is not an approved medicine in any jurisdiction. The material supplied here is unapproved, research-grade laboratory material sold strictly for in-vitro and preclinical research use only — not for human use.
How is eloralintide reconstituted and stored?
Keep the lyophilised powder at −20 °C in the freezer. Reconstitute with bacteriostatic water by directing it down the vial wall rather than onto the powder, then swirl gently — do not shake. After reconstitution, refrigerate at 1–6 °C and protect from light. Avoid repeated freeze–thaw cycles, which can damage the fatty-acid tail.
Is this page medical advice? Can I use Eloralintide for my health?
No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.
Where do I find Eloralintide specs, purity certificates and pricing?
Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.
Related peptide guides
Other compounds researchers often read about alongside Eloralintide.
Scientific sources & further reading
Primary literature and registries for Eloralintide, plus mainstream coverage of the peptide category. Research use only - not medical advice.
Databases & literature:
Peptides in the news:
Ready to order? View full product specs
Access concentration, batch info, variants, and current pricing on our shop.
Also known as: Eloralintide, LY3841136, Selective Amylin Receptor Agonist, Long-Acting Amylin Analogue
PRECISION. PURITY. PERFORMANCE.
Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.
Shop
Research
Support
Ways to Pay
Shop by goal
Shop by compound
Shop by region
Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.
All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.
Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.
© 2026 New-U Research Compounds · new-u.io